Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 3 12Phase NA 8Phase 1/2 8Phase 4 6Phase 2/3 5Phase 1 3

Status

Completed 9Unknown 8Terminated 7Withdrawn 1

Sponsor Class

OTHER 6UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 8

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Hepatocellular 4Recurrence 2Neoplasms 1HCC 1Gastrointestinal Neoplasms 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase NA × Unknown × Sorafenib × Clear all
NCT05391867 2022-05-26

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Sir Salimullah Medical College Mitford Hospital

Phase NA Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02529761 2019-08-01

TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma

Air Force Military Medical University, China

Phase NA Unknown
330 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03730675 2018-12-21

Irradiation Stent Placement Plus TACE for HCC and PVTT

Zhongda Hospital

Phase NA Unknown
308 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown
430 enrolled

HCC

NCT02187081 2017-03-28

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Southwest Hospital, China

Phase NA Unknown
380 enrolled

Recurrence

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown
20 enrolled

Neoplasms, Recurrence

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT02537158 2016-03-15

Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection

ChineseAMS

Phase NA Unknown
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡